1. Introduction Halophytic plants are adapted to saline and arid environments, where they are exposed to intense abiotic stress. These conditions can stimulate the accumulation of secondary metabolites, including phenolic compounds, flavonoids, terpenoids, and sterol-related constituents, which may contribute to antioxidant and protective activity [ 1, 2, 3]. Nanophyton iliense U.P. Pratov is a poorly studied halophytic species growing in Kazakhstan. Although previous phytochemical data suggest that this plant may contain biologically active metabolites [ 4], its potential as a source of extract-based topical formulations has not been sufficiently evaluated. Therefore, the development of a suitable semi-solid delivery system may help assess the practical pharmaceutical relevance of this species [ 5, 6, 7]. The added value of the present study lies in connecting the previously reported phytochemical potential of N. iliense with its practical formulation development. In particular, it has not been clearly demonstrated whether a chemically complex extract containing both polar phenolic compounds and lipophilic constituents can be incorporated into a homogeneous semi-solid formulation for topical use. Thus, this work focuses not only on the evaluation of extract composition and antioxidant activity, but also on its translation into an initial gel formulation followed by preliminary pharmaceutical quality assessment. Plant-derived secondary metabolites, including phenolic compounds, flavonoids, and terpenoids, have attracted significant attention due to their diverse biological and therapeutic potential, including antioxidant, protective, and disease-modulating effects [ 8]. Oxidative stress, caused by an imbalance between the production of reactive oxygen species (ROS) and the antioxidant defense system, is known to play a key role in the pathogenesis of numerous diseases, including chronic inflammation, cardiovascular disorders, and neurodegenerative conditions [ 9]. Therefore, the search for new natural antioxidants remains an important direction in modern pharmaceutical research. To address these limitations, increasing attention has been devoted to the development of drug delivery systems that can enhance the stability and effectiveness of bioactive compounds. Topical formulations, especially gel-based systems, represent a convenient and efficient approach for the localized administration of active substances. Gels are characterized by favorable rheological properties, ease of application, and the ability to form uniform films on the skin surface, which can improve the retention and controlled release of active compounds. In addition, polymer-based gels, such as those prepared using carbopol or carboxymethylcellulose, are widely used in pharmaceutical practice due to their biocompatibility, stability, and ability to modulate drug release [ 13, 14]. N. iliense U.P. Pratov is a halophytic plant species native to arid and saline regions of Central Asia. Plants growing under such extreme environmental conditions are known to accumulate a diverse range of secondary metabolites as part of their adaptive mechanisms [ 15, 16, 17]. These compounds, including phenolics, flavonoids, and triterpenoids, are often associated with pronounced biological activities [ 18, 19]. Despite its ecological significance and potential as a source of bioactive substances, the integration of N. iliense bioactive compounds into pharmaceutical formulations remains insufficiently studied. The aim of this study was to characterize the phytochemical composition of N. iliense extract, evaluate its antioxidant and preliminary safety profile, and develop a gel formulation suitable for preliminary topical formulation studies. The study combines botanical, chemical, biological, and technological evaluation in order to determine whether the extract can be incorporated into a stable semi-solid dosage form. 2. Materials and Methods 2.1. Plant Material The aerial parts of N. iliense U.P. Pratov were collected in 2024 during the flowering stage in the foothills of the Bugaty region, Kazakhstan. The plant material was identified using classical botanical methods, including route-orientational, ecological-systematic, and ecological-geographical approaches. Taxonomic identification was performed according to the reference work Flora of Kazakhstan and verified using international botanical databases including the International Plant Names Index (IPNI) and Plants of the World Online (POWO). The collected plant material was cleaned from soil impurities, washed with distilled water, and fixed in 40% ethanol prior to anatomical analysis. 2.2. Morphological and Anatomical Analysis Morphological characteristics of N. iliense were studied using standard botanical methods. Diagnostic structures of the plant were photographed using a digital camera attached to a microscope. For anatomical analysis, transverse sections of the plant stem were prepared from fixed plant material using an OL-ZCO 30 freezing microtome (INMEDPROM, Yaroslavl, Russia) according to the generally accepted pharmacognostic method described in the State Pharmacopoeia of the Republic of Kazakhstan [ 20]. The prepared sections were mounted on slides, covered with coverslips, and examined using an MC-300 microscope (Micros Handelsgesellschaft m.b.H., Vienna, Austria) at ×180 magnification. Microphotographs were obtained for documentation and morphometric analysis. 2.3. GC–MS Analysis Chemical profiling of the plant extracts was performed using gas chromatography–mass spectrometry (GC–MS). The analysis was carried out on an Agilent 7890A gas chromatograph equipped with an Agilent 7693 autosampler and coupled with an Agilent 5975C mass spectrometer (Agilent Technologies Inc., Santa Clara, CA, USA). Chromatographic separation was performed using an HP-5MS capillary column (60 m × 0.25 mm i.d., 0.25 µm film thickness). Helium was used as the carrier gas at a constant flow rate of 1 mL/min. The GC oven temperature program was as follows: initial temperature 50 °C (0.5 min), increased at 8 °C/min to 190 °C, then at 4 °C/min to 280 °C and held for 10 min. The injector temperature was set at 280 °C with a split ratio of 50:1. The injection volume was 1 µL. The mass spectrometer operated with an electron ionization energy of 70 eV. The ion source, quadrupole, and transfer line temperatures were maintained at 230 °C, 150 °C, and 280 °C, respectively. Mass spectra were recorded in the range of 45–450 m/z after an 8 min solvent delay. Compound identification was performed by comparison with the NIST mass spectral library (version 2.3) [ 21]. 2.4. HPLC Analysis High-performance liquid chromatography (HPLC) analysis was carried out using a Shimadzu LC-40 liquid chromatograph (Shimadzu Corporation, Kyoto, Japan). A 10 µL aliquot of the plant extract was injected into a C18 chromatographic column (250 mm × 4.6 mm, 5 µm particle size). The mobile phase consisted of acetonitrile and 1% acetic acid in water at a flow rate of 1 mL/min. The column temperature was maintained at 40 °C. Data acquisition and processing were performed using Shimadzu LabSolutions LC/GC software (version 5.114; Shimadzu Corporation, Kyoto, Japan). Reference standards including catechin, epicatechin, and naringin were used for compound identification based on retention times and peak area comparison [ 22]. 2.5. Determination of Antioxidant Activity (FRAP Assay) The antioxidant activity of the plant extract was determined using the ferric reducing antioxidant power (FRAP) assay. Briefly, 0.1 mL of the test solution (0.25–1.0 mg/mL) was mixed with 0.25 mL of 0.2 M phosphate buffer (pH 6.6) and 0.25 mL of 1% potassium hexacyanoferrate (III). The mixture was incubated at 50 °C for 20 min. The reaction was terminated by adding 0.25 mL of 10% trichloroacetic acid followed by centrifugation at 3000 rpm for 10 min. The supernatant (0.5 mL) was mixed with 0.5 mL distilled water and 0.1 mL of 0.1% FeCl 3 solution. Absorbance was measured at 700 nm. Gallic acid was used as the reference antioxidant. All measurements were performed in triplicate [ 23]. 2.6. Determination of Antiradical Activity (DPPH Assay) Antiradical activity was evaluated using the DPPH radical scavenging assay. A 0.1 mL aliquot of extract solution (0.25–1.0 mg/mL) was mixed with 3 mL of 6 × 10 −5 M DPPH solution. The mixture was incubated in the dark for 30 min and absorbance was measured at 520 nm. Radical scavenging activity (ARA) was calculated according to the following equation: ARA (%) = (A 0 − A t)/A 0 ୍ଠ ୧୦୦ where A 0 is the absorbance of the control and A t is the absorbance of the sample. All measurements were performed in triplicate [ 24]. The tested concentrations refer to the prepared extract solutions used in the assay. The IC50 value was estimated from the concentration–response data by linear interpolation between the two concentrations surrounding 50% radical scavenging activity. 2.7. Cytotoxicity Assay Cytotoxic activity of the extract was evaluated using the Artemia salina lethality assay. Artemia salina eggs were incubated in artificial seawater under aeration until larvae hatched. One-day-old larvae were exposed to different concentrations of the plant extract. The experiments were conducted in triplicate at 20 ± 2 °C under natural photoperiod conditions. The mortality of larvae in the treated groups was compared with the control group. The extract was considered toxic if larval mortality exceeded 50% [ 25]. 2.8. Ethics Statement No ethical approval was required for this study. The toxicity assessment was conducted using Artemia salina nauplii as a preliminary invertebrate model; therefore, separate ethics committee approval was not required. 3. Results This section presents the morphological, anatomical, phytochemical, and biological activity results obtained from the study of Nanophyton iliense U.P. Pratov. 3.1. Morphological Characteristics of Nanophyton iliense The morphological characteristics of N. iliense U.P. Pratov were investigated using plant material collected from the Bugaty foothills during the flowering stage. N. iliense is a perennial halophytic semi-shrub characterized by a compact cushion-shaped growth habit, which represents an adaptation to arid and saline environments. The collected specimens exhibited the characteristic morphological features of the species, including densely branched shoots, succulent leaves, and reproductive structures typical of the genus. Representative images of the plant in its natural habitat, air-dried material, whole plant morphology, and reproductive organs are presented in Figure 1 and were used to confirm the botanical identity of the studied material. 3.2. Extraction Technology of Nanophyton iliense The extraction of bioactive compounds from N. iliense was performed using a systematically designed process aimed at maximizing the recovery of chemically diverse constituents while preserving their stability. The extraction strategy was based on the assumption that the plant contains phytochemicals of varying polarity, which justified the use of a hydroethanolic solvent system [ 30]. The overall extraction workflow is presented in Figure 2. The process included raw material preparation, hydroethanolic extraction, clarification, and concentration steps leading to the formation of a crude extract. The aerial parts of the plant were dried and ground to a particle size of 1–3 mm to enhance mass transfer efficiency. Extraction was carried out using 70% ( v/ v) ethanol at a plant-to-solvent ratio of 1:10 ( w/ v) for 24 h at room temperature with periodic stirring [ 30]. Following extraction, the mixture was allowed to settle and subsequently filtered to remove insoluble residues. The resulting filtrate was concentrated under reduced pressure using a rotary evaporator, yielding a viscous crude extract. The extraction process resulted in approximately 40.4 g of extract, indicating efficient recovery of bioactive compounds [ 30]. The obtained extract was stored at 4 °C and subsequently used for phytochemical profiling, antioxidant activity evaluation, and formulation into a gel-based delivery system [ 4]. 3.3. Total Polyphenol Content The total polyphenol content of N. iliense extract was determined using the Folin–Ciocalteu method and expressed as gallic acid equivalents (GAE). The assay revealed a polyphenol content of 485.05 mg GAE/L, indicating an exceptionally high concentration of phenolic compounds in the analyzed extract [ 31]. In comparison with other plant extracts analyzed under identical conditions, N. iliense demonstrated markedly higher polyphenol levels ( Table 1). The content observed in this study substantially exceeded those of Calendula officinalis (24.71 mg GAE/L), Chamomilla recutita (37.39 mg GAE/L), Leonurus species (46.81 mg GAE/L), Potentilla species (78.55 mg GAE/L), and even Helichrysum arenarium (171.86 mg GAE/L), highlighting the distinctive phytochemical profile of the studied species. Overall, these results identify N. iliense as an exceptionally rich source of phenolic antioxidants, supporting its potential application in pharmaceutical formulations, particularly in topical and semi-solid delivery systems [ 5, 7]. 3.4. GC–MS Analysis of Nanophyton iliense Extracts The GC–MS data are presented as relative peak area percentages; therefore, these results should be interpreted as semi-quantitative phytochemical profiling rather than absolute quantitative determination. The differences observed between sampling dates were interpreted descriptively and were not subjected to statistical significance testing. In addition to GC–MS analysis, a comprehensive phytochemical investigation of N. iliense using high-resolution LC-DAD-QToF-MS has been previously reported, enabling the tentative identification of 81 metabolites [ 4]. These compounds included hydroxycinnamic acid amides, phenolic acids, flavonoids (including glycosides), amino acids, organic acids, sulfated derivatives, and nucleosides, reflecting a high level of chemical diversity [ 22]. Among the identified constituents, the flavonoid isorhamnetin-3-O-rutinoside (narcissin) was isolated and structurally confirmed, while an additional metabolite with the molecular formula C 17H 14O 5 was detected but could not be conclusively characterized. The predominance of phenylpropanoid-derived compounds observed in the LC-MS study complements the GC–MS findings and highlights the presence of both polar and non-polar bioactive constituents in the extract [ 4]. Despite some quantitative variability between sampling dates, the overall GC–MS profile remained consistent. Squalene was identified as the predominant compound in several samples, with relative abundances ranging from 26.69% to 96.42%, indicating its dominant contribution to the non-polar fraction. Phytol acetate was also consistently detected in high amounts (37.94–42.43%), suggesting a stable presence of diterpenoid derivatives across all analyzed samples. Phytol-related diterpenoid derivatives were therefore considered representative components of the lipophilic fraction of the extract. However, because the GC–MS data were based on relative peak area percentages, these values should not be interpreted as absolute phytol content or purity. Fatty acid methyl esters, including hexadecanoic acid methyl ester and unsaturated C18 derivatives (linoleic and oleic acid methyl esters), were detected in all samples, contributing to the lipid-rich composition of the extract. In addition, phytosterols such as β-sitosterol and stigmasterol, along with triterpenoids including β-amyrin, were identified, indicating the presence of structurally diverse secondary metabolites with established biological relevance. The predominance of lipophilic compounds observed in the GC–MS profile can be explained by the extraction conditions and solvent properties, which favor the recovery of non-polar constituents [ 30]. Such composition is typical for plant extracts obtained under conditions promoting the diffusion of hydrophobic molecules from plant matrices. Overall, the combined GC–MS and LC-MS data demonstrate a clear predominance of both lipophilic and phenolic bioactive compounds. From a pharmaceutical perspective, these compounds are of particular interest due to their ability to interact with biological membranes, contributing to membrane stabilization and potentially enhancing the penetration of active substances in topical delivery systems [ 5, 8]. This aspect is especially relevant for the development of gel-based formulations. 3.5. HPLC Analysis of Nanophyton iliense Extract HPLC analysis of N. iliense extract was performed under the chromatographic conditions described above. The chromatogram of the reference standards used for compound identification is presented in Figure 3, and the corresponding analytical parameters are summarized in Table 2. The chromatographic analysis of the plant extract was carried out under identical conditions. The resulting chromatogram is shown in Figure 4, while the quantitative results are presented in Table 3. The chromatographic profiles of the standards and the extract demonstrated well-defined peaks at comparable retention times, indicating the presence of target phenolic compounds. A comparison of retention times confirmed the presence of catechin, epicatechin, and naringin in the analyzed extract. The retention times of the detected peaks (8.349, 10.410, and 17.587 min) were in good agreement with those of the reference standards (8.373, 10.443, and 17.422 min), supporting reliable compound identification. The HPLC results were used for preliminary marker identification and concentration estimation based on reference standards; therefore, they should not be interpreted as a fully validated quantitative analytical method. Preliminary concentration estimation indicated that naringin was the predominant phenolic marker (101.732 mg/L), followed by epicatechin (79.119 mg/L) and catechin (25.639 mg/L). The predominance of naringin indicates that flavonoid glycosides play a central role in the phenolic profile of the extract. The chromatogram of the extract ( Figure 4) shows that the peak corresponding to naringin exhibits the highest intensity, which is consistent with its dominant concentration in the sample. These findings indicate that flavonoids constitute a major fraction of the phenolic profile of N. iliense extract. The presence of these compounds is in good agreement with the antioxidant activity observed in the FRAP and DPPH assays, supporting their contribution to the redox properties of the extract [ 31, 35]. 3.6. The Biological Activity of Nanophyton iliense Extract 3.6.1. Antioxidant Activity (FRAP Assay) The results demonstrate a clear and consistent concentration-dependent increase in reducing power. The optical density of the extract increased from 0.6211 at 0.25 mg/mL to 1.4787 at 1.0 mg/mL, indicating a progressive enhancement of antioxidant capacity with increasing concentration [ 23]. This behavior suggests that the active redox compounds are present in sufficient amounts and exhibit cumulative activity. In comparison with the reference antioxidant compound gallic acid, the extract showed lower absolute values across all concentrations; however, the difference decreased significantly at higher concentrations. At 1.0 mg/mL, the extract reached approximately 79% of the activity of gallic acid (1.4787 vs. 1.8705), indicating a relatively high reducing potential. 3.6.2. Antiradical Activity The extract exhibited a pronounced concentration-dependent increase in radical scavenging activity. At the lowest concentration (0.25 mg/mL), the activity was relatively low (26.98%), indicating limited radical neutralization under dilute conditions. However, a sharp increase was observed at 0.5 mg/mL, where the activity reached 69.18%, representing a more than twofold increase. At higher concentrations, the extract demonstrated strong antiradical activity, reaching 88.61% at 0.75 mg/mL and 90.06% at 1.0 mg/mL. These values approach the activity of the reference compound gallic acid (94.69%), indicating that at sufficiently high concentrations, the extract exhibits comparable radical scavenging efficiency. Based on the concentration–response data, the IC50 value of N. iliense extract in the DPPH assay was estimated by linear interpolation between 0.25 and 0.5 mg/mL, which corresponded to the two concentrations surrounding 50% radical scavenging activity. The estimated IC50 value was approximately 0.39 mg/mL under the present experimental conditions. These results demonstrate the preliminary in vitro antioxidant potential of N. iliense extract. However, FRAP and DPPH assays are chemical antioxidant tests and should not be interpreted as direct evidence of topical therapeutic efficacy. 3.6.3. Cytotoxicity Assessment The cytotoxic activity of the extract was evaluated using the Artemia salina lethality assay as a preliminary model for biological safety [ 25]. The results are summarized in Table 6. The extract of N. iliense did not exhibit cytotoxic effects in the Artemia salina assay at the tested concentrations of 1, 5, and 10 mg/mL. The survival rate of larvae remained consistently high, and no significant mortality was observed. These findings indicate the absence of general toxicity in this preliminary invertebrate model within the tested concentration range. However, the Artemia salina assay cannot be used as a direct substitute for dermal safety evaluation. In contrast, the reference compound Actinomycin D demonstrated pronounced cytotoxic activity, with mortality values ranging from 63% to 96%, confirming the sensitivity and validity of the assay [ 25]. 3.7. Development of Gel Formulation and Composition Justification The selection of excipients was guided by the mixed chemical nature of N. iliense extract, which contains both polar phenolic compounds and lipophilic constituents such as terpenoids, phytosterols, and fatty acid derivatives. Therefore, the formulation required a semi-solid matrix capable of incorporating chemically diverse components while maintaining homogeneity and acceptable topical properties. Lecigel was selected as the main gelling and structuring agent because it provides a stable gel network and supports the formation of a homogeneous semi-solid system. Glycerin was included as a humectant and wetting agent to improve the hydration properties and application characteristics of the gel. Tween 80 was used as a non-ionic surfactant to facilitate the dispersion of lipophilic constituents within the aqueous gel phase and to improve the uniform distribution of the extract. Benzyl alcohol was included as a preservative to support microbiological quality during storage. Purified water served as the continuous phase for the hydrophilic fraction of the formulation. Among the tested compositions, Gel No. 4 provided the most balanced combination of homogeneity, consistency, spreadability, and absence of greasy residue, which justified its selection for further quality evaluation. This screening was used as an initial formulation selection step and was not intended to replace detailed pharmaceutical quality testing. A series of five experimental gel formulations were prepared using different combinations of gelling agents, surfactants, and stabilizing components. The formulations were evaluated based on key physicochemical and organoleptic parameters [ 39], including homogeneity, consistency, appearance, spreadability, and residual greasiness ( Table 7). The comparative analysis revealed pronounced differences in structural organization and application properties among the tested formulations. Gel No. 1 demonstrated acceptable homogeneity but was characterized by excessive fluidity and the presence of a greasy residue, which may negatively affect patient acceptability. Gel No. 2 and Gel No. 3 showed insufficient structural stability and poor homogeneity, including the presence of dispersed phases and air inclusions, indicating incomplete integration of the extract into the gel matrix. Gel No. 5, although relatively homogeneous, exhibited low viscosity and limited spreadability, which restrict its practical application. Based on these results, Gel No. 4 was selected as the optimal formulation for further development. The composition of the selected formulation is presented in Table 8. The optimized formulation consisted of N. iliense extract as the active component, Lecigel as the gelling agent, glycerin as a humectant, Tween 80 as a surfactant and solubilizing agent, benzyl alcohol as a preservative, and purified water as the dispersion medium. Overall, this composition was selected as the most balanced system for further quality evaluation because it combined acceptable homogeneity, consistency, spreadability, and absence of greasy residue [ 39]. 3.8. Gel Preparation Technology The gel containing Nanophyton iliense extract was prepared using a sequential process designed to ensure uniform distribution of the active component and formation of a stable semi-solid system [ 40]. The overall workflow of the preparation process is presented in Figure 7. The process began with accurate weighing of all components according to the optimized formulation. Precise measurement of each component ensured consistency and reproducibility of the formulation [ 40]. The gel base was prepared by dispersing Lecigel in purified water under controlled stirring conditions. Mixing was carried out at a stirring speed of 20 ± 5 rpm for approximately 30 min to ensure complete hydration of the polymer and formation of a uniform gel structure [ 40, 41]. Separately, the extract-containing phase was prepared by mixing N. iliense extract with glycerin until a homogeneous system was obtained. This step facilitated uniform dispersion of the extract and improved its compatibility with the hydrophilic gel matrix [ 41]. The prepared extract phase was then gradually incorporated into the gel base under continuous stirring. Controlled addition prevented the formation of aggregates and ensured uniform distribution of the active component throughout the system. Following incorporation, the formulation was subjected to homogenization at 20 ± 5 rpm for 30 min. This step was critical for obtaining a stable and homogeneous gel with consistent structural properties [ 40, 42]. After homogenization, the gel was filled into tubes as primary packaging under controlled conditions. Secondary packaging and labeling were performed to ensure product integrity, identification, and compliance with pharmaceutical requirements [ 43]. 3.9. Quality Evaluation of the Gel Formulation The quality of the developed Nanophyton iliense gel was evaluated in accordance with pharmacopoeial requirements for semi-solid dosage forms, including the State Pharmacopoeia of the Republic of Kazakhstan and the Eurasian Economic Union Pharmacopoeia [ 20, 44]. The assessment included organoleptic characteristics, identification of the active component, pH determination, homogeneity, viscosity assessment, microbiological purity, quantitative analysis, as well as packaging, labeling, and storage conditions. The quality parameters and acceptance criteria of the developed gel are summarized in Table 9. Identification of the active component was performed using gas chromatography in accordance with SP RK Vol. 1, Section 2.2.28, where phytol was selected as a marker compound [ 20, 21]. The observed retention time of approximately 20.3 min confirmed the presence of the phytol marker in the gel formulation and supported the incorporation of the lipophilic fraction of N. iliense extract into the gel matrix. Quantitative determination of phytol was carried out using gas chromatography in accordance with SP RK Vol. 1, Section 2.2.28 [ 20, 21]. The phytol content was not less than 3%, supporting preliminary standardization of the formulation. The pH of the gel was determined potentiometrically according to Ph. Eur. 2.2.3 and EAEU Pharmacopoeia requirements (Section 2.1.2.3). The formulation complied with the established acceptance criterion of pH 6.5–7.5, which is suitable for topical application and helps minimize the risk of skin irritation while maintaining formulation stability [ 44, 45]. Homogeneity was assessed by visual examination in accordance with EAEU Pharmacopoeia (Section 2.1.9.10), confirming the physical uniformity of the gel matrix and the absence of visible particles or phase separation [ 44]. Microbiological purity was evaluated in accordance with pharmacopoeial methods for non-sterile dosage forms (Category 2), including total aerobic microbial count (TAMC) and total yeast and mold count (TYMC), according to SP RK Vol. 1, Sections 2.3.12, 2.6.13 and 5.1.4. The formulation complied with acceptable limits and showed an absence of pathogenic microorganisms [ 20, 47]. 4. Discussion The absence of cytotoxicity in the Artemia salina assay indicates a favorable preliminary safety profile, which is essential for further pharmaceutical development [ 25]. Although this model provides only an initial assessment, the results support further evaluation of the extract in topical formulation studies. Therefore, phytol alone cannot fully represent the entire phytochemical profile of the extract. Future standardization of the gel should include a broader marker system combining a lipophilic marker, such as phytol, with phenolic markers such as naringin, epicatechin, or catechin. In addition, content uniformity should be evaluated by analyzing samples collected from different parts of the gel batch to confirm the homogeneous distribution of marker compounds throughout the formulation. The present study should be regarded as a preliminary formulation and quality evaluation rather than a complete pharmaceutical characterization. The antioxidant activity was assessed using in vitro chemical assays, which do not fully reflect the complexity of biological skin systems [ 23, 24]. In addition, full analytical validation of the GC–MS and HPLC methods, including linearity, precision, accuracy, LOD/LOQ, repeatability, and sample preparation reproducibility, should be included in future standardization studies of the extract and gel formulation. 5. Conclusions This study showed that Nanophyton iliense extract contains both lipophilic and phenolic bioactive constituents and demonstrates marked antioxidant activity in FRAP and DPPH assays. The absence of cytotoxicity in the Artemia salina model supports its preliminary safety within the tested concentration range. The extract was successfully incorporated into a Lecigel-based semi-solid formulation. Among the tested samples, Gel No. 4 demonstrated the most suitable characteristics, including homogeneity, appropriate consistency, good spreadability, and absence of greasy residue. These results support the potential of N. iliense as a source of antioxidant compounds for topical formulation development. Further studies should focus on release behavior, skin permeation, long-term stability, and in vivo or advanced ex vivo evaluation. Supplementary Materials The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pharmaceutics18060710/s1. Supplementary Section S1: Additional morphological and anatomical characteristics of Nanophyton iliense; Figure S1: Root system morphology of Nanophyton iliense; Figure S2: Leaf morphology of Nanophyton iliense; Figure S3: Microscopic structure of the leaf of Nanophyton iliense; Tables S1–S6: GC–MS identified compounds in Nanophyton iliense extracts obtained from different sampling dates (May–June). Author Contributions Conceptualization, L.N.K., R.B.A. and G.S.I.; methodology, S.E.M., A.T.M., R.B.A. and Y.V.S.; validation, M.K.K., G.S.I. and Y.V.S.; formal analysis, M.K.K. and Y.V.S.; investigation, S.E.M., N.Z.A., A.T.M., Y.N. and G.N.M.; resources, G.N.M.; data curation, A.S.M.; visualization, N.Z.A., A.S.M. and Y.N.; writing—original draft preparation, A.S.M.; writing—review and editing, L.N.K., S.E.M., M.K.K., N.Z.A., A.T.M., A.S.M., Y.N., R.B.A., G.S.I., Y.V.S. and G.N.M.; supervision, L.N.K., R.B.A. and G.S.I.; project administration, R.B.A. All authors have read and agreed to the published version of the manuscript. Funding This research received no external funding. Institutional Review Board Statement Ethical review and approval were not required for this study because it did not involve human participants, human data, human biological materials, vertebrate animals, mammals, or regulated laboratory animals. The toxicity assessment was performed using Artemia salina nauplii as a preliminary invertebrate model; therefore, separate ethics committee approval was not required. Informed Consent Statement Not applicable. Data Availability Statement The original contributions presented in this study are included in the article/ Supplementary Material. Further inquiries can be directed to the corresponding authors. Acknowledgments The authors would like to thank the laboratories of L.N. Gumilyov Eurasian National University for providing research facilities. Conflicts of Interest The authors declare no conflicts of interest. Abbreviations The following abbreviations are used in this manuscript: LC-MS Liquid Chromatography–Mass Spectrometry HPLC High-Performance Liquid Chromatography FRAP Ferric Reducing Antioxidant Power DPPH 2,2-Diphenyl-1-picrylhydrazyl ARA Antiradical Activity GA Gallic Acid N. iliense Nanophyton iliense NIST National Institute of Standards and Technology IPNI International Plant Names Index POWO Plants of the World Online References Koch, W.; Zagórska, J.; Michalak-Tomczyk, M.; Karav, S.; Wawruszak, A. Plant Phenolics in the Prevention and Therapy of Acne: A Comprehensive Review. Molecules 2024, 29, 4234. [] [ CrossRef] Gulcin, İ. Antioxidants: A comprehensive review. Arch. Toxicol. 2025, 99, 1893–1997. [] [ CrossRef] Nisa, R.U.; Nisa, A.U.; Tantray, A.Y.; Shah, A.H.; Jan, A.T.; Shah, A.A.; Wani, I.A. Plant phenolics with promising therapeutic applications against skin disorders: A mechanistic review. J. Agric. Food Res. 2024, 16, 101090. [] [ CrossRef] Kudaibergenova, M.K.; Datkhayev, U.M.; Avula, B.; Katragunta, K.; Tatapudi, K.K.; Aldana-Mejía, J.A.; Khan, I.A.; Akhtayeva, N.Z.; Mukhametzhan, A.S.; Kiyekbayeva, L.N.; et al. Phytochemical Analysis of Plant Nanophyton iliense U.P. U.P. Pratov from Kazakhstan Using LC-MS. Molecules 2026, 31, 918. [] [ CrossRef] Hashempur, M.H.; Ghorat, F.; Karami, F.; Jahanbin, A.; Nouraei, H.; Abbasi, M.; Jafari, M.; Zare, A.; Barzegar, S.; Zareshahrabadi, Z. Topical Delivery Systems for Plant-Derived Antimicrobial Agents: A Review of Current Advances. Int. J. Biomater. 2025, 2025, 4251091. [] [ CrossRef] Kawee-ai, A. Advancing Gel Systems with Natural Extracts: Antioxidant, Antimicrobial Applications, and Sustainable Innovations. Gels 2025, 11, 125. [] [ CrossRef] Pavaloiu, R.-D.; Neagu, G.; Albulescu, A.; Deaconu, M.; Petrica, A.-L.; Bubueanu, C.; Sha’at, F. Development and Characterization of Topical Gels Containing Lipid Nanosystems Loaded with Echinacea purpurea. Gels 2025, 11, 801. [] [ CrossRef] Rayamajhi, A.; Gyawali, N.; Karki, D.; Pérez-Caltzontzin, L.E.; Peña-Corona, S.I.; Cortés, H.; Adhikari, A.; Leyva-Gómez, G.; Uprety, Y.; Habtemariam, S.; et al. Magnolol and its Semi-Synthetic Derivatives: A Comprehensive Review of Anti-Cancer Mechanisms, Pharmacokinetics, and Future Therapeutic Potential. Discov. Oncol. 2025, 16, 683. [] [ CrossRef] Shahidi, F.; Zhong, Y. Measurement of antioxidant activity. J. Funct. Foods 2015, 18, 757–781. [] [ CrossRef] Bernatoniene, J.; Kopustinskiene, D.M. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules 2018, 23, 965. [] [ CrossRef] Silva, G.C.; Rodrigues, R.A.F.; Bottoli, C.B.G. In vitro diffusion of plant phenolics through the skin: A review update. Int. J. Cosmet. Sci. 2024, 46, 239–261. [] [ CrossRef] Schafer, N.; Balwierz, R.; Biernat, P.; Ochędzan-Siodłak, W.; Lipok, J. Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the Stratum Corneum. Mol. Pharm. 2023, 20, 3278–3297. [] [ CrossRef] Rowe, R.C.; Sheskey, P.J.; Quinn, M.E. Handbook of Pharmaceutical Excipients, 9th ed.; Pharmaceutical Press: London, UK, 2024. [] EMA. EMA Guideline on Excipients; EMA: Amsterdam, The Netherlands, 2024. [] Cioară, N.O.; Miteluț, A.C. Halophyte Bioactive Compounds: A Review of Their Chemical Composition and Biological Activities. Sci. Pap. Ser. A Agron. 2025, LXVIII, 753–764. [] Bacler-Żbikowska, B.; Hutniczak, A.; Pilawa, B.; Chodurek, E.; Zdybel, M.; Piekarska-Stachowiak, A.; Fatmawati, D.; Malinowski, L.; Woźniak, G. The Current State of Knowledge About Changes in the Synthesis of the Secondary Metabolites Caused by Habitat Conditions and Microbial Activity. Agronomy 2025, 15, 2251. [] [ CrossRef] Azeem, M.; Pirjan, K.; Qasim, M.; Mahmood, A.; Javed, T.; Muhammad, H.; Yang, S.; Dong, R.; Ali, B.; Rahimi, M. Salinity stress improves antioxidant potential by modulating physio-biochemical responses in Moringa oleifera Lam. Sci. Rep. 2023, 13, 2895. [] [ CrossRef] Salehi, B.; Quispe, C.; Sharifi-Rad, J.; Cruz-Martins, N.; Nigam, M.; Mishra, A.P.; Konovalov, D.A.; Orobinskaya, V.; Abu-Reidah, I.M.; Zam, W.; et al. Phytosterols: From Preclinical Evidence to Potential Clinical Applications. Front. Pharmacol. 2021, 11, 599959. [] [ CrossRef] Barp, L.; Miklavčič Višnjevec, A.; Moret, S. Analytical Determination of Squalene in Extra Virgin Olive Oil and Olive Processing By-Products, and Its Valorization as an Ingredient in Functional Food—A Critical Review. Molecules 2024, 29, 5201. [] [ CrossRef] Tulegenova, A.U.; Berdimuratova, G.D.; Dauletbakova, F.D.; Adekenov, S.M.; Arystanova, S.N.; Baimukanov, S.A. State Pharmacopoeia of the Republic of Kazakhstan; Ministry of Health: Astana, Kazakhstan, 2015; Volume 1. Sparkman, O.D.; Penton, Z.; Kitson, F.G. Gas Chromatography and Mass Spectrometry: A Practical Guide, 3rd ed.; Academic Press: New York, NY, USA, 2024. [] Wolfender, J.-L.; Marti, G.; Thomas, A.; Bertrand, S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 2015, 1382, 136–164. [] [ CrossRef] Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [] [ CrossRef] Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a Free Radical Method to Evaluate Antioxidant Activity (DPPH). LWT–Food Sci. Technol. 1995, 28, 25–30. [] [ CrossRef] Araya, X.; Okumu, M.; Durán, G.; Gómez, A.; Gutiérrez, J.M.; León, G. Assessment of the Artemia salina toxicity assay as a substitute of the mouse lethality assay in the determination of venom-induced toxicity and preclinical efficacy of antivenom. Toxicon X 2024, 22, 100195. [] [ CrossRef] Grigore, M.N.; Toma, C. Definition and Classification of Halophytes. In Anatomical Adaptations of Halophytes; Springer: Cham, Switzerland, 2017. [] [ CrossRef] Fahn, A. Plant Anatomy, 4th ed.; Pergamon Press: Oxford, UK, 1990. [] Flowers, T.J.; Colmer, T.D. Salinity tolerance in halophytes. New Phytol. 2008, 179, 945–963. [] [ CrossRef] Metcalfe, C.R.; Chalk, L. Anatomy of the Dicotyledons, 2nd ed.; Oxford University Press: Oxford, UK, 1979. [] Chemat, F.; Vian, M.A.; Cravotto, G. Green Extraction of Natural Products: Concept and Principles. Int. J. Mol. Sci. 2012, 13, 8615–8627. [] [ CrossRef] Prior, R.L.; Wu, X.; Schaich, K. Standardized Methods for the Determination of Antioxidant Capacity and Phenolics in Foods and Dietary Supplements. J. Agric. Food Chem. 2005, 53, 4290–4302. [] [ CrossRef] Pungin, A.; Lartseva, L.; Loskutnikova, V.; Shakhov, V.; Popova, E.; Skrypnik, L.; Krol, O. Effect of Salinity Stress on Phenolic Compounds and Antioxidant Activity in Halophytes Spergularia marina (L.) Griseb. and Glaux maritima L. Cultured In Vitro. Plants 2023, 12, 1905. [] [ CrossRef] Ayupova, R.; Švajdlenka, E.; Zemlička, M.; Ibadullayeva, G.; Raganina, K.; Alimova, U.; Nokerbek, S.; Botabayeva, R.; Kiyekbayeva, L.; Mombekov, S. Comparative Phytochemical Profiling of Essential Oils from Selected Abies Species and Analysis of Their Antifungal and Antiradical Activity. Pharmaceutics 2026, 18, 26. [] [ CrossRef] Kuljarusnont, S.; Iwakami, S.; Iwashina, T.; Tungmunnithum, D. Flavonoids and Other Phenolic Compounds for Physiological Roles, Plant Species Delimitation, and Medical Benefits: A Promising View. Molecules 2024, 29, 5351. [] [ CrossRef] Kiss, A.; Papp, V.A.; Pál, A.; Prokisch, J.; Mirani, S.; Toth, B.E.; Alshaal, T. Comparative Study on Antioxidant Capacity of Diverse Food Matrices: Applicability, Suitability and Inter-Correlation of Multiple Assays to Assess Polyphenol and Antioxidant Status. Antioxidants 2025, 14, 317. [] [ CrossRef] Dunn, W.B.; Erban, A.; Weber, R.J.M.; Creek, D.J.; Brown, M.; Breitling, R.; Hankemeier, T.; Goodacre, R.; Neumann, S.; Kopka, J.; et al. Mass appeal: Metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 2013, 9, 44–66. [] [ CrossRef] Bhowmik, D.; Gopinath, H.; Kumar, B.P.; Duraivel, S.; Kumar, K.P.S. Recent Advances in Novel Topical Drug Delivery System. Pharma Innov. 2012, 1, 12–31. [] Almoshari, Y. Novel Hydrogels for Topical Applications: An Updated Comprehensive Review Based on Source. Gels 2022, 8, 174. [] [ CrossRef] [ PubMed] Alexander, A.; Khichariya, A.; Gupta, S.; Patel, R.J.; Giri, T.K.; Tripathi, D.K. Recent Expansions in an Emergent Novel Drug Delivery Technology: Emulgel. J. Control. Release 2013, 171, 122–132. [] [ CrossRef] [ PubMed] Aulton, M.E.; Taylor, K.M.G. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, 5th ed.; Elsevier: London, UK, 2017. [] Tadros, T.F. Formulation of Disperse Systems: Science and Technology; Wiley-VCH: Berlin, Germany, 2014. [] Sinko, P.J. Martin’s Physical Pharmacy and Pharmaceutical Sciences, 7th ed.; Lippincott Williams & Wilkins: Ambler, PA, USA, 2016. [] European Medicines Agency (EMA). Guidelines on Good Manufacturing Practice (GMP) for Medicinal Products; EMA: Amsterdam, The Netherlands, 2022. [] Eurasian Economic Commission. Eurasian Economic Union Pharmacopoeia; Eurasian Economic Commission: Moscow, Russia, 2020; Volume 1. [] European Pharmacopoeia Commission. European Pharmacopoeia, 11th ed.; EDQM: Strasbourg, France, 2023. [] GOST 17768–90; Medicinal Products. Packaging, Labeling, Transportation and Storage. USSR State Committee for Standards: Moscow, Russia, 1990. EMA. Guideline on Microbiological Quality of Non-Sterile Products; European Medicines Agency: Amsterdam, The Netherlands, 2022. [] WHO. Technical Report Series No. 1010: Annex 2–Good Manufacturing Practices for Pharmaceutical Products; World Health Organization: Geneva, Switzerland, 2020. [] Crozier, A.; Clifford, M.N.; Ashihara, H. (Eds.) Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet; Blackwell Publishing: Oxford, UK, 2006. [] [ CrossRef] Barry, B.W. Dermatological Formulations: Percutaneous Absorption; Marcel Dekker: New York, NY, USA, 2002. [] Benson, H.A.E.; Watkinson, A.C. Transdermal and Topical Drug Delivery: Principles and Practice; Wiley: Hoboken, NJ, USA, 2012. [] [ CrossRef] Prausnitz, M.R.; Langer, R. Transdermal Drug Delivery. Nat. Biotechnol. 2008, 26, 1261–1268. [] [ CrossRef] [ PubMed] Figure 1. Morphological features of Nanophyton iliense U.P. Pratov: ( a) plant growing in its natural habitat in the Bugaty foothills; ( b) air-dried plant material used for analysis; ( c) whole plant specimen showing the characteristic cushion-shaped growth habit; ( d) close-up view of the reproductive structures of the plant. Figure 1. Morphological features of Nanophyton iliense U.P. Pratov: ( a) plant growing in its natural habitat in the Bugaty foothills; ( b) air-dried plant material used for analysis; ( c) whole plant specimen showing the characteristic cushion-shaped growth habit; ( d) close-up view of the reproductive structures of the plant. Figure 2. Graphical representation of the extraction process of Nanophyton iliense from plant material to crude extract. Figure 2. Graphical representation of the extraction process of Nanophyton iliense from plant material to crude extract. Figure 3. Chromatogram of reference standards detected at 272 nm. Figure 3. Chromatogram of reference standards detected at 272 nm. Figure 4. HPLC chromatogram of Nanophyton iliense extract detected at 272 nm. Figure 4. HPLC chromatogram of Nanophyton iliense extract detected at 272 nm. Figure 5. Concentration-dependent reducing activity of N. iliense extract compared with gallic acid in the FRAP assay. Figure 5. Concentration-dependent reducing activity of N. iliense extract compared with gallic acid in the FRAP assay. Figure 6. Concentration-dependent DPPH radical scavenging activity of N. iliense extract compared with gallic acid. Figure 6. Concentration-dependent DPPH radical scavenging activity of N. iliense extract compared with gallic acid. Figure 7. Technological stages in the preparation of Nanophyton iliense gel, including base preparation, extract incorporation, homogenization, and packaging. Figure 7. Technological stages in the preparation of Nanophyton iliense gel, including base preparation, extract incorporation, homogenization, and packaging. Table 1. Total polyphenol content of selected plant extracts determined under identical Folin–Ciocalteu assay conditions. Table 1. Total polyphenol content of selected plant extracts determined under identical Folin–Ciocalteu assay conditions. Sample Total Polyphenols (mg GAE/L) Nanophyton iliense 485.05 Calendula officinalis 24.71 Chamomilla recutita 37.39 Leonurus sp. 46.81 Helichrysum arenarium 171.86 Potentilla sp. 78.55 Table 2. Results of HPLC analysis of reference standards. Table 2. Results of HPLC analysis of reference standards. Retention Time (min) Area Height Concentration (mg/L) Name 8.373 63,691 4214 64.828 Catechin 10.443 71,059 5162 64.272 Epicatechin 17.422 132,983 11,244 64.313 Naringin Table 3. Results of HPLC analysis of the extract of N. iliense U.P. Pratov. Table 3. Results of HPLC analysis of the extract of N. iliense U.P. Pratov. Retention Time (min) Area Height Concentration (mg/L) Name 8.349 25,189 1816 25.639 Catechin 10.410 87,473 3972 79.119 Epicatechin 17.587 210,358 14,597 101.732 Naringin Table 4. FRAP absorbance values of N. iliense extract and gallic acid at different concentrations. Table 4. FRAP absorbance values of N. iliense extract and gallic acid at different concentrations. No. Samples Optical Density Value at Concentration (mg/mL) 0.25 0.5 0.75 1.0 1 Gallic acid (GA) 1.3480 1.5237 1.7191 1.8705 2 Extract of Nanophyton iliense U.P. Pratov ( N. iliense) 0.6211 0.8301 1.1445 1.4787 Table 5. DPPH radical scavenging activity (%) of N. iliense extract and gallic acid at different concentrations. Table 5. DPPH radical scavenging activity (%) of N. iliense extract and gallic acid at different concentrations. No. Samples Optical Density Value at Concentration (mg/mL) 0.25 0.5 0.75 1.0 1 Gallic acid (GA) 81.22 86.19 92.21 94.69 2 Extract of Nanophyton iliense U.P. Pratov ( N. iliense) 26.98 69.18 88.61 90.06 Table 6. Results of cytotoxic activity evaluation. Table 6. Results of cytotoxic activity evaluation. Studied Substances Concentration (mg/mL) Number of Larvae in Control Number of Larvae in Sample Survival of Larvae in Control (%) Survival of Larvae in Sample (%) Mortality, A (%) Neurotoxicity (%) Alive Dead Alive Dead Paralyzed Actinomycin D 10 22 0 0 22 0 96 0 96 0 5 22 0 1 25 0 96 4 92 0 1 22 0 9 18 0 96 33 63 0 Extract of Nanophyton iliense U.P. Pratov ( N. iliense) 10 22 0 25 1 0 96 96 0 0 5 22 0 25 1 0 96 96 0 0 1 22 0 26 1 0 96 96 0 0 Table 7. Preliminary organoleptic and technological screening of experimental gel formulations. Table 7. Preliminary organoleptic and technological screening of experimental gel formulations. Formulation Homogeneity Consistency Appearance Spreadability Residue Decision Gel 1 Homogeneous Fluid Yellowish Moderate Greasy Rejected Gel 2 Non-homogeneous Thick Opaque Poor Non-greasy Rejected Gel 3 Non-homogeneous Very thick Yellow Low Non-greasy Rejected Gel 4 Homogeneous Soft Transparent yellow Good Non-greasy Selected Gel 5 Homogeneous Very fluid Yellowish Low Non-greasy Rejected Table 8. Composition and functional role of excipients in the optimized gel formulation. Table 8. Composition and functional role of excipients in the optimized gel formulation. Component Amount (g) Function Nanophyton iliense extract 3.0 Active component Lecigel 3.0 Gelling agent Glycerin 8.0 Humectant Tween 80 2.5 Emulsifier/solubilizer Benzyl alcohol 0.5 Preservative Purified water up to 100 Vehicle Table 9. Quality evaluation parameters of the optimized Nanophyton iliense gel formulation. Table 9. Quality evaluation parameters of the optimized Nanophyton iliense gel formulation. Parameter Specification Method/Reference Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Development and Characterization of a Nanophyton iliense-Based Gel for Topical Application
